Literature DB >> 21048824

Platelet Precursor Cells Can Be Generated from Cultured Human CD34+ Progenitor Cells But Display Recirculation into Hematopoietic Tissue upon Transfusion in Mice.

Christian Hintze1, Brigitte Rüster, Erhard Seifried, Reinhard Henschler.   

Abstract

BACKGROUND: Whereas ex vivo expanded megakaryocytic progenitor cells have been investigated for their ability to support platelet regeneration, the question whether more mature platelet-like particles expanded from hematopoietic progenitor cells may be useful for transfusion purposes remains largely elusive.
METHODS: Human peripheral blood progenitor cells (PBPCs) were enriched using surface expression of CD34 by immunoselection. CD34+ enriched PBPCs were expanded ex vivo in serum-free medium supplemented with cytokines. As a proof-of-principle, distribution of expanded CD61+ particles was analyzed after transfusion into Non-Obese Diabetic/ Severe Combined Immunodeficiency (NOD/SCID) mice.
RESULTS: Highest ex vivo expansion for CD41+/CD61 + cells was achieved when medium was supplemented with SCF, TPO and IL-3. During expansion culture, CD34 marker expression decreased from 85 to 2-8%, while megakaryocytic cells appeared and CD41 and CD61 expression increased from 3 to about 30%. After transfusion of the expanded cells in NOD/SCID mice, CD61 + cells located mainly to bone marrow and to a lesser degree to spleen, but also circulated in blood.
CONCLUSIONS: Platelet-like particles using cytokine-substituted serumfree medium can be generated efficiently from CD34+ expansion cultures, but mainly home to hematopoietic tissue.

Entities:  

Year:  2010        PMID: 21048824      PMCID: PMC2928839          DOI: 10.1159/000316975

Source DB:  PubMed          Journal:  Transfus Med Hemother        ISSN: 1660-3796            Impact factor:   3.747


  17 in total

1.  Ex vivo culture of human CD34+ cord blood cells with thrombopoietin (TPO) accelerates platelet engraftment in a NOD/SCID mouse model.

Authors:  Yvette van Hensbergen; Laurus F Schipper; Anneke Brand; Manon C Slot; Mick Welling; Alma J Nauta; Willem E Fibbe
Journal:  Exp Hematol       Date:  2006-07       Impact factor: 3.084

2.  Thrombopoietin requires additional megakaryocyte-active cytokines for optimal ex vivo expansion of megakaryocyte precursor cells.

Authors:  J L Williams; G G Pipia; N S Datta; M W Long
Journal:  Blood       Date:  1998-06-01       Impact factor: 22.113

3.  The threshold for prophylactic platelet transfusions in adults with acute myeloid leukemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.

Authors:  P Rebulla; G Finazzi; F Marangoni; G Avvisati; L Gugliotta; G Tognoni; T Barbui; F Mandelli; G Sirchia
Journal:  N Engl J Med       Date:  1997-12-25       Impact factor: 91.245

4.  A mouse model to study organ homing behaviour of haemopoietic progenitor cells reveals high selectivity but low efficiency of multipotent progenitors to home into haemopoietic organs.

Authors:  R Henschler; Z Fehervizyova; R Bistrian; E Seifried
Journal:  Br J Haematol       Date:  2004-07       Impact factor: 6.998

Review 5.  The mpl ligand: molecular and cellular biology of the critical regulator of megakaryocyte development.

Authors:  K Kaushansky
Journal:  Stem Cells       Date:  1994       Impact factor: 6.277

6.  Long-term platelet production assessed in NOD/SCID mice injected with cord blood CD34+ cells, thrombopoietin-amplified in clinical grade serum-free culture.

Authors:  Gianfranco Mattia; Luisa Milazzo; Francesca Vulcano; Massimiliano Pascuccio; Giampiero Macioce; Hamisa Jane Hassan; Adele Giampaolo
Journal:  Exp Hematol       Date:  2007-11-26       Impact factor: 3.084

7.  Reticulated platelet monitoring after autologous peripheral haematopoietic progenitor cell transplantation.

Authors:  Giovanna Martinelli; Patrizia Merlo; Rita Fantasia; Francesco Gioia; Giovanni Crovetti
Journal:  Transfus Apher Sci       Date:  2009-04-23       Impact factor: 1.764

8.  Fast but durable megakaryocyte repopulation and platelet production in NOD/SCID mice transplanted with ex-vivo expanded human cord blood CD34+ cells.

Authors:  Stefania Bruno; Monica Gunetti; Loretta Gammaitoni; Eliana Perissinotto; Luisa Caione; Fiorella Sanavio; Franca Fagioli; Massimo Aglietta; Wanda Piacibello
Journal:  Stem Cells       Date:  2004       Impact factor: 6.277

Review 9.  Human platelets circulating in mice: applications for interrogating platelet function and survival, the efficacy of antiplatelet therapeutics, and the molecular basis of platelet immunological disorders.

Authors:  P J Newman; R Aster; B Boylan
Journal:  J Thromb Haemost       Date:  2007-07       Impact factor: 5.824

Review 10.  From hematopoietic stem cells to platelets.

Authors:  Y Chang; D Bluteau; N Debili; W Vainchenker
Journal:  J Thromb Haemost       Date:  2007-07       Impact factor: 5.824

View more
  1 in total

Review 1.  Manufacturing blood ex vivo: a futuristic approach to deal with the supply and safety concerns.

Authors:  Vimal K Singh; Abhishek Saini; Kohichiro Tsuji; P B Sharma; Ramesh Chandra
Journal:  Front Cell Dev Biol       Date:  2014-06-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.